Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.
Publication
, Journal Article
Khamash, DF; Voskertchian, A; Tamma, PD; Akinboyo, IC; Carroll, KC; Milstone, AM
Published in: J Pediatric Infect Dis Soc
September 25, 2019
The epidemiology of Staphylococcus aureus infection in children is dynamic. We conducted a retrospective observational study on pediatric clinical cultures, performed between 2005 and 2017, that grew S aureus to determine temporal trends in antibiotic resistance. Although methicillin resistance declined, clindamycin and trimethoprim-sulfamethoxazole resistance increased significantly, especially among community-onset isolates.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
September 25, 2019
Volume
8
Issue
4
Start / End Page
351 / 353
Location
England
Related Subject Headings
- Trimethoprim, Sulfamethoxazole Drug Combination
- Staphylococcus aureus
- Staphylococcal Infections
- Retrospective Studies
- Methicillin-Resistant Staphylococcus aureus
- Humans
- Drug Resistance, Multiple, Bacterial
- Clindamycin
- Child
- Anti-Bacterial Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Khamash, D. F., Voskertchian, A., Tamma, P. D., Akinboyo, I. C., Carroll, K. C., & Milstone, A. M. (2019). Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections. J Pediatric Infect Dis Soc, 8(4), 351–353. https://doi.org/10.1093/jpids/piy062
Khamash, Dina F., Annie Voskertchian, Pranita D. Tamma, Ibukunoluwa C. Akinboyo, Karen C. Carroll, and Aaron M. Milstone. “Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.” J Pediatric Infect Dis Soc 8, no. 4 (September 25, 2019): 351–53. https://doi.org/10.1093/jpids/piy062.
Khamash DF, Voskertchian A, Tamma PD, Akinboyo IC, Carroll KC, Milstone AM. Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections. J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):351–3.
Khamash, Dina F., et al. “Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.” J Pediatric Infect Dis Soc, vol. 8, no. 4, Sept. 2019, pp. 351–53. Pubmed, doi:10.1093/jpids/piy062.
Khamash DF, Voskertchian A, Tamma PD, Akinboyo IC, Carroll KC, Milstone AM. Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections. J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):351–353.
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
September 25, 2019
Volume
8
Issue
4
Start / End Page
351 / 353
Location
England
Related Subject Headings
- Trimethoprim, Sulfamethoxazole Drug Combination
- Staphylococcus aureus
- Staphylococcal Infections
- Retrospective Studies
- Methicillin-Resistant Staphylococcus aureus
- Humans
- Drug Resistance, Multiple, Bacterial
- Clindamycin
- Child
- Anti-Bacterial Agents